Jw Pharmac (001060) - Total Liabilities
Based on the latest financial reports, Jw Pharmac (001060) has total liabilities worth ₩235.90 Billion KRW (≈ $159.87 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Jw Pharmac equity growth rate to track the company's year-over-year net asset growth rate.
Jw Pharmac - Total Liabilities Trend (2000–2025)
This chart illustrates how Jw Pharmac's total liabilities have evolved over time, based on quarterly financial data. See Jw Pharmac (001060) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Jw Pharmac Competitors by Total Liabilities
The table below lists competitors of Jw Pharmac ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
HCR Co Ltd
SHG:688500
|
China | CN¥273.37 Million |
|
Shandong Minhe Animal Husbandry Co Ltd
SHE:002234
|
China | CN¥1.90 Billion |
|
PetroVietnam Transportation Corp
VN:PVT
|
Vietnam | ₫10.38 Trillion |
|
Hibiscus Petroleum BHD
KLSE:5199
|
Malaysia | RM4.73 Billion |
|
Tande Co Ltd
SHG:600665
|
China | CN¥18.60 Billion |
|
Aydem Yenilenebilir Enerji AS
IS:AYDEM
|
Turkey | TL31.75 Billion |
|
Revenio Group Corporation
HE:REG1V
|
Finland | €30.90 Million |
|
Norske Skog Asa
OL:NSKOG
|
Norway | Nkr8.29 Billion |
Liability Composition Analysis (2000–2025)
This chart breaks down Jw Pharmac's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Jw Pharmac (001060) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.64 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jw Pharmac's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jw Pharmac (2000–2025)
The table below shows the annual total liabilities of Jw Pharmac from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩235.90 Billion ≈ $159.87 Million |
-14.25% |
| 2024-12-31 | ₩275.11 Billion ≈ $186.44 Million |
-27.53% |
| 2023-12-31 | ₩379.60 Billion ≈ $257.25 Million |
-5.62% |
| 2022-12-31 | ₩402.21 Billion ≈ $272.57 Million |
-9.52% |
| 2021-12-31 | ₩444.51 Billion ≈ $301.24 Million |
+30.12% |
| 2020-12-31 | ₩341.62 Billion ≈ $231.51 Million |
-0.44% |
| 2019-12-31 | ₩343.12 Billion ≈ $232.52 Million |
+2.83% |
| 2018-12-31 | ₩333.68 Billion ≈ $226.13 Million |
-7.34% |
| 2017-12-31 | ₩360.10 Billion ≈ $244.03 Million |
-3.91% |
| 2016-12-31 | ₩374.76 Billion ≈ $253.97 Million |
-3.43% |
| 2015-12-31 | ₩388.07 Billion ≈ $262.99 Million |
+4.80% |
| 2014-12-31 | ₩370.29 Billion ≈ $250.94 Million |
-4.72% |
| 2013-12-31 | ₩388.63 Billion ≈ $263.37 Million |
-11.57% |
| 2012-12-31 | ₩439.48 Billion ≈ $297.83 Million |
-11.54% |
| 2011-12-31 | ₩496.84 Billion ≈ $336.70 Million |
+44.69% |
| 2006-12-31 | ₩343.37 Billion ≈ $232.70 Million |
-4.23% |
| 2005-12-31 | ₩358.53 Billion ≈ $242.97 Million |
+6.02% |
| 2004-12-31 | ₩338.16 Billion ≈ $229.17 Million |
+12.95% |
| 2003-12-31 | ₩299.40 Billion ≈ $202.90 Million |
+5.10% |
| 2002-12-31 | ₩284.88 Billion ≈ $193.06 Million |
-3.88% |
| 2001-12-31 | ₩296.37 Billion ≈ $200.84 Million |
-5.01% |
| 2000-12-31 | ₩311.99 Billion ≈ $211.43 Million |
-- |
About Jw Pharmac
JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam steri… Read more